ADC Therapeutics, Cancer Research U.K. deal

ADC Therapeutics partnered with the research center's commercial arm Cancer Research Technology Ltd. to develop antibody-drug conjugates (ADCs) to treat cancer. The partners will use undisclosed antibodies and peptides from the research center and ADC Therapeutics' "warhead" and linker chemistries. ADC Therapeutics will initially fund preclinical studies of the ADCs. Details were not disclosed. ...